Enanta Pharmaceuticals
ENTA
#8290
Rank
โ‚น30.69 B
Marketcap
โ‚น1,054
Share price
-2.18%
Change (1 day)
3.21%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2026 : โ‚น9.49 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has โ‚น9.49 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-09-30$โ‚น18.02 B-31.07%
2022-09-30$โ‚น26.15 B-11.82%
2021-09-30$โ‚น29.65 B-11.67%
2020-09-30$โ‚น33.57 B2.37%
2019-09-30$โ‚น32.80 B14.92%
2018-09-30$โ‚น28.54 B44.87%
2017-09-30$โ‚น19.70 B9.19%
2016-09-30$โ‚น18.04 B16.6%
2015-09-30$โ‚น15.47 B68.39%
2014-09-30$โ‚น9.18 B32.93%
2013-09-30$โ‚น6.91 B197.78%
2012-09-30$โ‚น2.32 B115.41%
2011-09-30$โ‚น1.07 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚น7.657 T 80,567.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น3.527 T 37,067.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-โ‚น552.99 Billion-5,925.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.901 T 19,933.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.943 T 41,440.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น2.198 T 23,056.69%๐Ÿ‡บ๐Ÿ‡ธ USA